title: Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
authors.forename: M
authors.initials: M
authors.lastname: Bertelli
authors.forename: R
authors.initials: R
authors.lastname: Luongo
authors.forename: L
authors.initials: L
authors.lastname: Barcella
authors.forename: P
authors.initials: P
authors.lastname: Cavalli
mesh_terms: D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018579:Patient Selection; D010597:Pharmacogenetics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors